1. Market Research
  2. > Diagnostics Market Trends
  3. > 2015-2019 Japanese Hospital Microbiology Testing Market

2015-2019 Japanese Hospital Microbiology Testing Market

  • June 2015
  • -
  • Venture Planning Group
  • -
  • 891 pages

This new report from VPGMarketResearch contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital microbiology testing market, including: 

  • Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. 
  • Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms. 
  • Volume and sales forecasts for 80 microbiology tests performed in Japanese hospital laboratories. 
  • Instrumentation technologies and feature comparison of leading analyzers. 
  • Sales and market shares of leading suppliers. 
  • Emerging diagnostic technologies and their potential market applications. 
  • Product development opportunities. 
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 
  • Business opportunities and strategic recommendations for suppliers. 

             Contains 891 pages and 75 tables

This new report from VPGMarketResearch contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital microbiology testing market, including:

Table Of Contents

2015-2019 Japanese Hospital Microbiology Testing Market
Table of Contents

Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. Aeromonas
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Arboviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Babesiosis
a. Background
7. Bacillary Epithelioid Angiomatosis (BEA)
And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Blastocystis Hominis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

9. Brucella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Campylobacter
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. Candida
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. Chagas Disease
a. Background
13. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. Clostridium Difficile
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. Coxsackieviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. Creutzfeldt-Jakob's Disease
a. Background
b. Diagnostic Tests
c. Vaccines

19. Cryptosporidium Parvum
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
20. Cyclospora Cayetanensis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
21. Cytomegalovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
22. Ebola Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
23. E. Coli
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
24. EchoVirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
25. Encephalitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
26. Enteroviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
27. Epstein-Barr Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
28. Giardia Lamblia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

29. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
30. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
31. Hantavirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
32. Helicobacter Pylori
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
33. Hepatitis
a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
e. Vaccines and Drugs
34. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
36. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
37. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

38. Lyme Disease
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
40. Malaria
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
41. Measles (Rubeola)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
42. Meningitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
43. Microsporidium
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
44. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
45. Mumps
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
46. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
47. Papillomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

48. Parvovirus B19
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
49. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
50. Polyomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
52. Rabies
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
54. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
56. Rubella(MEASLES)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
57. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

58. Septicemia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
59. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
60. Staphylococcus Aureus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
61. Streptococci
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
62. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
63. Toxoplasmosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
64. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
65. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
66. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
67. West Nile Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

68. Yersina
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements

C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio
- Gen-Probe
- Hologic

- ID Biomedical
- Innogenetics/Solvay
- Kreatech
- Life Technology
- Lonza
- Nanogen/Elitech
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- Wako

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
A 33-Country Survey of the Cancer Diagnostic Testing Market: Sales Forecasts and Supplier Shares for 40 Tumor Markers--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Competitive Strategies, Opportunities

A 33-Country Survey of the Cancer Diagnostic Testing Market: Sales Forecasts and Supplier Shares for 40 Tumor Markers--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Competitive Strategies, Opportunities

  • $ 47 400
  • Industry report
  • February 2016
  • by Venture Planning Group

This report is delivered in 10-15 working days This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, ...

A 33-Country Survey of the Cancer Diagnostic Testing Market: Sales Forecasts and Supplier Shares for 40 Tumor Markers--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains (DataPack)

A 33-Country Survey of the Cancer Diagnostic Testing Market: Sales Forecasts and Supplier Shares for 40 Tumor Markers--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains (DataPack)

  • $ 47 400
  • Industry report
  • February 2016
  • by Venture Planning Group

This DataPack contains tables from VPGMarketResearch.com new report, "A 33-Country Survey of the Cancer Diagnostic Testing Market: Sales Forecasts and Supplier Shares for 40 Tumor Markers--Oncogenes, Biochemical ...

2016 World Hemostasis Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers (DataPack)

2016 World Hemostasis Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers (DataPack)

  • $ 21 100
  • Industry report
  • January 2016
  • by Venture Planning Group

This DataPack contains tables from VPGMarketResearch.com new report, "2016 World Hemostasis Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers.” ...


Download Unlimited Documents from Trusted Public Sources

Diagnostics Industry in the US

  • November 2015
    12 pages
  • Diagnostics  

    Diagnostic Test  

  • United States  

View report >

Diagnostics Industry in the US - Forecast

  • October 2015
    23 pages
  • Diagnostics  

    In Vitro Diagno...  

  • United States  

View report >

Global Diagnostics Markets

  • October 2015
    40 pages
  • Diagnostics  

    Diagnostic  

    HIV Diagnostic  

  • World  

    United States  

View report >

Diagnostics Industry

5 months ago

Related Market Segments :

Diagnostic Test

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.